# Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis

> **NCT03696290** · PHASE4 · TERMINATED · sponsor: **University of Dundee** · enrollment: 34 (actual)

## Conditions studied

- Bronchiectasis Adult

## Interventions

- **DRUG:** Aztreonam lysine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03696290
- **Lead sponsor:** University of Dundee
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-10-19
- **Primary completion:** 2024-11-26
- **Final completion:** 2025-03-04
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Poor recruitment
- **Last updated:** 2026-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03696290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03696290, "Value of Inhaled Treatment With Aztreonam Lysine in Bronchiectasis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03696290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*